Gemina Laboratories Ltd
CNSX:GLAB
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.06
1.25
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| CA |
G
|
Gemina Laboratories Ltd
CNSX:GLAB
|
4.6m CAD |
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
33.1B USD |
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
19.4B USD |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
14.3B USD |
Loading...
|
|
| FR |
|
Biomerieux SA
PAR:BIM
|
12B EUR |
Loading...
|
|
| US |
C
|
Caris Life Sciences Inc
NASDAQ:CAI
|
7.2B USD |
Loading...
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
42.8B CNY |
Loading...
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
8.7T KRW |
Loading...
|
|
| CH |
|
Siegfried Holding AG
SIX:SFZN
|
4.4B CHF |
Loading...
|
|
| IT |
|
DiaSorin SpA
MIL:DIA
|
3.8B EUR |
Loading...
|
|
| UK |
|
Abcam PLC
LSE:ABC
|
2.8B GBP |
Loading...
|
Market Distribution
| Min | -9 940 586.9% |
| 30th Percentile | -85.9% |
| Median | -7.8% |
| 70th Percentile | 5.5% |
| Max | 60 777.6% |
Other Profitability Ratios
Gemina Laboratories Ltd
Glance View
Gemina Laboratories Ltd. (Gemina) is a Canada-based biotechnology company. Gemina operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. It is engaged in biosensor and diagnostic services with a transformative, patented, proprietary chemistry that powers next-generation testing platforms for a wide range of pathogens that affect human health and wellness. Gemina's technology drives testing platforms that are fast, affordable and accurate, and easily self-administered. Its development pipeline includes platforms for the rapid testing of COVID-19, influenza and other viruses. Gemina is focused on infectious respiratory diseases and the recovery from them. It has developed a first-generation technology (the Generation 1 Technology), which it has included within an initial demonstration product namely: a point-of-care lateral flow assay to test whether a person is infected with COVID-19 (the Legio-XTM COVID Rapid Antigen Test).
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Gemina Laboratories Ltd is -26 874.3%, which is above its 3-year median of -34 322.3%.
Over the last 7 months, Gemina Laboratories Ltd’s Net Margin has increased from -44 353.2% to -26 874.3%. During this period, it reached a low of -44 353.2% on Apr 30, 2025 and a high of -26 874.3% on Dec 1, 2025.